Compare ACLX & KYIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ACLX | KYIV |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United Arab Emirates |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.1B |
| IPO Year | 2022 | N/A |
| Metric | ACLX | KYIV |
|---|---|---|
| Price | $67.97 | $12.22 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $113.75 | N/A |
| AVG Volume (30 Days) | ★ 870.4K | N/A |
| Earning Date | 02-26-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $35,898,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $309.32 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $47.86 | N/A |
| 52 Week High | $94.07 | N/A |
| Indicator | ACLX | KYIV |
|---|---|---|
| Relative Strength Index (RSI) | 49.04 | N/A |
| Support Level | $66.00 | N/A |
| Resistance Level | $76.50 | N/A |
| Average True Range (ATR) | 3.50 | 0.00 |
| MACD | 0.85 | 0.00 |
| Stochastic Oscillator | 46.58 | 0.00 |
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.
Kyivstar Group Ltd is engaged in mobile communication.